U.S. markets closed
  • S&P 500

    4,326.51
    -23.42 (-0.54%)
     
  • Dow 30

    34,160.78
    -7.31 (-0.02%)
     
  • Nasdaq

    13,352.78
    -189.34 (-1.40%)
     
  • Russell 2000

    1,931.29
    -45.18 (-2.29%)
     
  • Crude Oil

    87.37
    +0.76 (+0.88%)
     
  • Gold

    1,795.10
    +2.00 (+0.11%)
     
  • Silver

    22.75
    +0.07 (+0.33%)
     
  • EUR/USD

    1.1147
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.8070
    -0.0410 (-2.22%)
     
  • GBP/USD

    1.3378
    -0.0003 (-0.02%)
     
  • USD/JPY

    115.4330
    +0.1310 (+0.11%)
     
  • BTC-USD

    37,230.08
    +249.66 (+0.68%)
     
  • CMC Crypto 200

    813.93
    -5.57 (-0.68%)
     
  • FTSE 100

    7,554.31
    +84.53 (+1.13%)
     
  • Nikkei 225

    26,581.94
    +411.64 (+1.57%)
     

Is It Too Late to Buy Viatris Stock?

·4 min read
Is It Too Late to Buy Viatris Stock?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • VTRS

If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer's generic drugs business, Upjohn, and Mylan.